Aerovate Therapeutics Logo (full size)
Aerovate Therapeutics Logo icon/symbol
Aerovate Therapeutics Logo (full size) on a dark background
Aerovate Therapeutics Logo icon/symbol on a dark background
About Aerovate Therapeutics
Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. The company was incorporated in 2018 and is headquartered in Waltham, Massachusetts.
July 6th, 2024
